Alcon Inc.

NYSE:ALC

Medical - Instruments & Supplies

Healthcare
$75.26 +0.94%

+$0.61 today

Market cap
$36.15B
Beta
0.70
P/E (TTM)
38.7
EPS (TTM)
$1.67
Dividend yield
0.55%
52W Low $61.84High $92.55

Volume 4.74M

Average 1.91M

ALC EBITDA

Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.

Alcon Inc.NYSE: ALC

EBITDA · Q3 FY2026 · quarter ended Sep 2026

EBITDA grows in line with its trailing trend

Q3 FY2026 EBITDA of $676M rose 1.7% year over year, behind the +3.6% change in trailing-twelve-month EBITDA. Sequentially, it fell 15.5% from the prior quarter. Over 3 fiscal years it compounded at +12.8% a year.

Context

  • EBITDA amounted to 24.0% of revenue in FY2025, down 3.0 pp from a year earlier.
  • EBITDA increased in 2 of the last 3 fiscal years.

What to watch

Whether EBITDA reaches the consensus estimate from 12 analysts of $3.46B (+38.7%) for the fiscal year ending Dec 2026, a step up from the -6.8% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterSep 2026
$676M-15.5% QoQ
Last fiscal yearDec 2025
$2.5B-6.8% YoY
LTMSep 2026
$2.78B+3.6% YoY
EBITDA past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+1.7%+3.2%+1.5 pp
1 year-6.8%+38.7%+45.5 pp
3-year CAGR+12.8%+16.1%+3.4 pp
5-year CAGR+12.9%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA history

USD · from the income statement

Latest · FY2025
2.5B USD
Year-over-year change
-6.8%
4-year CAGR
+9.1%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA vs competitors

How ALC compares with its peers on the latest reported figures

  • ALC's LTM Sep 2026 EBITDA of $2.78B is the highest of the 8 companies compared; the peer median is -$4.11M.
  • Its year-over-year change of +3.6% is the 5th highest of 8, against a peer median of +27.7%.
  • EBITDA amounts to 25.4% of revenue for ALC, versus a peer median of 23.0%.
ALC Competitors Peer median
EBITDA for ALC and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ALCAlcon Inc.LTM Sep 2026$2.78B +3.6%+12.8%25.4%
COOThe Cooper Companies, Inc.LTM Jul 2026$910.3M -16.6%+6.2%21.5%
BLCOBausch + Lomb CorporationLTM Jun 2026$742M +61.3%-3.6%13.9%
LNSRLENSAR, Inc.LTM Mar 2026$33.96M +165.0%—58.8%
STAASTAAR Surgical CompanyLTM Apr 2026-$4.11M +87.8%—1.4%
SGHTSight Sciences, Inc.LTM Mar 2026-$31.68M +27.7%—39.8%
RXSTRxSight, Inc.LTM Mar 2026-$43.24M -86.4%—33.9%
GKOSGlaukos CorporationLTM Jun 2026-$140.99M -195.0%—23.0%
Peer median (excluding ALC) -$4.11M+27.7%+1.3%23.0%

Competitors are the stored peer set for ALC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue8.29B8.72B9.46B9.91B10.4B
Cost of Revenue3.64B3.97B4.21B4.4B4.66B
Gross Profit4.65B4.75B5.25B5.51B5.75B
Gross Margin56.1%54.5%55.5%55.6%55.2%
Research & Development842M702M859M876M990M
Selling, General & Admin3.08B3.07B3.21B3.25B3.45B
Operating Expenses4.07B4.08B4.21B4.1B4.39B
Depreciation & Amortization1.22B1.12B1.22B1.23B1.34B
EBITDA1.76B1.74B2.24B2.68B2.5B
EBITDA Margin21.2%20.0%23.7%27.0%24.0%
Operating Income580M672M1.04B1.41B1.36B
Operating Margin7.0%7.7%11.0%14.3%13.1%
Interest Income3.01M16.52M34M81.45M74M
Interest Expense120.26M138.4M189M186.18M204M
Other Income / Expenses(162M)(209M)(207M)(157M)(200M)
Income Before Tax418M463M832M1.26B1.16B
Pre-Tax Margin5.0%5.3%8.8%12.7%11.2%
Income Tax Expense42M128M(142M)238M180M
Net Income376M335M974M1.02B980M
Net Margin4.5%3.8%10.3%10.3%9.4%
EPS (Basic)0.770.681.982.061.99
EPS (Diluted)0.760.681.962.051.98
Weighted Avg Shares490M491.4M493M494.4M494.95M
Weighted Avg Shares (Diluted)493.4M494.4M496.5M497.5M496.2M

Alcon Inc.

NYSE:ALC

Intrinsic Alpha fair value

Locked

Current Price

$75.26

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.